Skip to main content Back to Top
Advertisement

8/25/2024

Phenylephrine Ophthalmic Solution

Products Affected - Description

    • Phenylephrine ophthalmic drops, Bausch Health, 2.5%, 10 mL bottle, 1 count, NDC 42702-0102-10

Reason for the Shortage

    • Akorn ceased operations in February 2023.
    • Bausch Health did not provide a reason for the shortage.
    • Lifestar has phenylephrine ophthalmic solution available.
    • Sandoz is no longer marketing phenylephrine ophthalmic solution.

Available Products

    • Phenylephrine ophthalmic drops, Bausch Health, 10%, 5 mL bottle, 1 count, NDC 42702-0103-05
    • Phenylephrine ophthalmic drops, Lifestar Pharma, LLC, 10%, 5 mL bottle, 1 count, NDC 70756-0612-30
    • Phenylephrine ophthalmic drops, Lifestar Pharma, LLC, 2.5%, 2 mL bottle, 1 count, NDC 70756-0629-25

Estimated Resupply Dates

    • Bausch Health has 2.5% phenylephrine in 10 mL bottles and on back order and the company estimates a release date in the first quarter of 2025.

Updated

Updated August 25, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created April 26, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT